Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-27 | Dr. Tagliaferri is currently a member of the Company’s Audit Committee. |
| 2022-03-01 | Dr. Tagliaferri has been serving as Senior Vice President and Executive Clinical Fellow for Nektar Therapeutics, a Nasdaq-listed company, since March 2020. |
| 2022-12-21 | Dr. Tagliaferri has been serving as Senior Vice President and Executive Clinical Fellow for Nektar Therapeutics. |
Data sourced from SEC filings. Last updated: 2025-07-01